| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.091 | 0.6 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.099 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.095 | 0.6 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |